Semaglutide Achieves 14% Weight Loss in Treatment-Resistant Hypothalamic Obesity
A 38-year-old woman with hypothalamic obesity following brain tumor treatment achieved remarkable 14% weight loss (131…
A 38-year-old woman with hypothalamic obesity following brain tumor treatment achieved remarkable 14% weight loss (131…
Analysis of 4 million breast cancer survivors reveals that GLP-1 receptor agonists emerge as a promising intervention b…
A 52-year-old woman lost 25 kg on semaglutide treatment, causing her implanted cardiac defibrillator to rotate within i…
GLP-1 receptor agonists achieved substantial weight reductions of 6.2 to 9.5 kilograms in patients managing both obesit…
Menopause hormone therapy (MHT) demonstrates measurable effects on body composition during the hormonal transition, spe…
Systematic analysis reveals that obesity involves a specific microbial signature: depletion of short-chain fatty acid-p…
The window of prenatal brain development may be far more vulnerable to maternal metabolic health than previously unders…
Cost barriers to cancer immunotherapy may have met their match through a dosing strategy that dramatically reduces expe…
Brain blood vessel dysfunction may precede the cognitive decline seen in Alzheimer's disease, yet the precise molecular…
Blood cancer patients face a critical window where molecular traces of disease predict impending relapse, yet standard…
GLP-1 receptor agonists showed no increased risk of bone healing failure (pseudoarthrosis) in diabetic patients undergo…
The nuclear protein YTHDC1 directly binds to m6A-modified TERT mRNA transcripts, stabilizing telomerase expression and…
Cardiovascular disease prevention may be entering a new era where a single injection could provide lasting cholesterol…
Childhood neuroblastoma diagnosis could become more precise and accessible as artificial intelligence proves capable of…
The long-standing debate about whether aging impairs motor learning may have been asking the wrong question entirely. R…
Women with hormone-positive metastatic breast cancer face critical treatment decisions after initial chemotherapy stabi…
Pancreatic cancer remains one of oncology's most formidable challenges, with five-year survival rates below 12% and lim…
Men facing aggressive prostate cancer surgery now have compelling evidence for a treatment approach that could dramatic…
Precision medicine has taken another significant leap forward with compelling evidence that targeting specific genetic…
Pancreatic ductal adenocarcinoma stands as medicine's most stubborn adversary, with five-year survival rates below 12 p…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.